Article
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
Journal of the National Cancer Institute - 18 May 2011
Wu Xifeng, Ye Yuanqing, Rosell Rafael, Amos Christopher I, Stewart David J, Hildebrandt Michelle A T, Roth Jack A, Minna John D, Gu Jian, Lin Jie, Buch Shama C, Nukui Tomoko, Ramirez Serrano Jose Luis, Taron Miquel, Cassidy Adrian, Lu Charles, Chang Joe Y, Lippman Scott M, Hong Waun Ki, Spitz Margaret R, Romkes Marjorie, Yang Ping
Abstract excerpt
BACKGROUND: Interindividual variation in genetic background may influence the response to chemotherapy and overall survival for patients with advanced-stage non-small cell lung cancer (NSCLC). METHODS: To identify genetic variants associated with poor overall survival in these patients, we conducted a genome-wide scan of 307,260 single-nucleotide polymorphisms (SNPs) in 327 advanced-stage NSCLC patients who...
Topics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Area Under Curve
- Carcinoma, Non-Small-Cell Lung
- Chemotherapy, Adjuvant
- Female
